1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
GIFA 23-02 - BIPOC Communities is sponsored by Pennsylvania Department of Drug and Alcohol Programs (DDAP). DDAP is accepting applications from organizations to establish or expand SUD-related services, community outreach, and/or education to BIPOC communities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations providing SUD-related services to BIPOC communities. Confirm the full requirements in the official notice before applying.
GIFA 23-02 - BIPOC Communities is funded by Pennsylvania Department of Drug and Alcohol Programs (DDAP). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Pennsylvania. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Commonwealth Financing Authority's statewide Local Share Account program accepts applications September 1 through November 30, 2026, funding public-interest projects from $25,000 in eligible costs up to $1,000,000 per grant request out of Pennsylvania gaming revenue. Nonprofits are not eligible applicants and must be sponsored by a county, municipality, authority, or development agency. Here is how the sponsorship structure actually works, what the three-month window is really for, and why the ownership-and-maintenance clause decides more applications than the project narrative.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read article